Breast tumours with high Notch3 levels are enriched in the triple-negative breast cancer (TNBC) subclass that lacks estrogen receptor, progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2) expression. Here, NOTCH3 is linked to triple-negative breast carcinoma.